Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edivoxetine augmentation in MDD partial responders to SSRI
NCT00840034Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edivoxetine in major depressive disorder (MDD), sponsored by Eli Lilly and Company. Started Feb 2009; status: completed.
02
Drugs
edivoxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00840034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00840034.